The Solventum V.A.C. Via System includes a 250 ml canister and the advanced V.A.C. VIA™ GRANUFOAM™ Spiral Dressing, making it a premier option for negative pressure wound therapy (NPWT). This system elevates wound recovery by maximizing tissue growth and reducing healing time through a controlled, vacuum-assisted process.

The compact canister, designed for five uses per case, allows for effective drainage management with minimal disruption.

Meanwhile, the medium-sized spiral dressing ensures optimal wound coverage and patient comfort. This makes it an extremely flexible and adaptable solution for a wide range of wound types and care settings.

Solventum V.A.C. Via System Features:

• Compact and portable design for convenient use and enhanced patient mobility.
• Utilizes negative pressure wound therapy to promote faster and more effective healing.
• GRANUFOAM™ Spiral Dressing ensures even distribution, adaptation to different wound shapes, and superior patient comfort.
• Easy-to-change canisters and dressings minimize disruption to the wound site and maximize hygiene.

Solventum V.A.C. Via System Uses:

• The Solventum V.A.C. Via System is designed for improved wound healing by creating a controlled, closed environment with negative pressure wound therapy.
• Suitable for a variety of acute and chronic wound types, it helps reduce edema and promote tissue granulation.
• Ideal for use in hospitals, clinics, and even at home under physician guidance, the V.A.C. Via System is particularly effective for postoperative wounds, pressure ulcers, diabetic ulcers, and traumatic wounds.
• Its compact design makes it suitable for patient mobility during the healing process.

Solventum V.A.C. Via System FAQs:

1. How often should the canister be replaced?
The canister should be replaced every time it reaches the designated septic level or as instructed by healthcare providers.

2. Is the system easy to use for home care?
Yes, the system is designed for ease of use and comes with comprehensive instructions, although professional guidance is recommended initially.